Back to Journals » OncoTargets and Therapy » Volume 12

Newly emergent acquired EGFR exon 18 G724S mutation after resistance of a T790M specific EGFR inhibitor osimertinib in non-small-cell lung cancer: a case report

Total article views   HTML views PDF downloads Totals
9,033 Dovepress* 6,600+ 1,136 7,736
PubMed Central* 2,433 419 2,852
Totals 9,033 1,555 10,588
*Since 18 December 2018
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 0 2

View citations on PubMed Central and Google Scholar